RapidPulse, Inc., a medical device company focused on minimally invasive vascular products for ischemic stroke, has secured $48.0M in Series B funding. The privately held firm is advancing the development of its RapidPulse™ Aspiration System.
This system includes a novel aspiration pump and catheters designed to allow rapid and consistent removal of blood clots from the brain. It's an important area of medical innovation, though the RapidPulse™ Aspiration System is not yet cleared for sale in the United States.
